AI in Precision Oncology: Revolutionizing Cancer Treatment Through Personalized Drug Discovery

Artificial intelligence (AI) is revolutionizing precision oncology by enabling early detection of cancer, accurate diagnosis, and personalized treatment plans. This research aligns the mechanisms and techniques stemming from AI with their implications towards advancements in cancer treatment, with particular focus on its role in personalization for the sake of precision medicinal diagnoses. AI-powered technologies have revolutionized cancer treatment from genetic profiling and pathology interpretation to predictive analytics and medical imaging analysis. Case examples show how AI can tailor treatments to individual patients, improve diagnostic accuracy, guide optimal treatment and monitor treatment response in real time. The Future of AI in Oncology section delves into potential future advancements in the field, discussing how AI technologies could accelerate drug discovery and development, enhance therapy outcomes, and facilitate greater patient engagement. Ultimately, artificial intelligence is not only reshaping cancer treatment; it is also providing patients worldwide with new hope for greater survival and quality of life. This study highlights some revolutionary frontiers of artificial intelligence, like virtual tumor boards, liquid biopsies, and the speeding of drug discovery processes,” the paper said in part. This article uses a narrative review approach to provide a holistic understanding of the transformative potential that artificial intelligence holds for cancer treatment, highlighting its current significance in cancer care and its future potential.